Medical treatment of diabetic retinopathy

被引:6
作者
Donaldson, M
Dodson, PM
机构
[1] Birmingham Heartlands Hosp, Dept Ophthalmol, Birmingham B9 5SS, W Midlands, England
[2] Birmingham Heartlands Hosp, Dept Diabet, Birmingham B9 5SS, W Midlands, England
[3] Birmingham Heartlands Hosp, Dept Endocrinol, Birmingham B9 5SS, W Midlands, England
关键词
D O I
10.1038/sj.eye.6700586
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
[No abstract available]
引用
收藏
页码:550 / 562
页数:13
相关论文
共 91 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]   Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor [J].
Aiello, LP ;
Bursell, SE ;
Clermont, A ;
Duh, E ;
Ishii, H ;
Takagi, C ;
Mori, F ;
Ciulla, TA ;
Ways, K ;
Jirousek, M ;
Smith, LEH ;
King, GL .
DIABETES, 1997, 46 (09) :1473-1480
[3]  
[Anonymous], 1991, Ophthalmology, V98, P757
[4]  
[Anonymous], 1995, DIABETES, V44, P968
[5]  
[Anonymous], 1976, Am J Ophthalmol, V81, P383
[6]   Bowman Lecture 1998 - Diabetic retinopathy: some cellular, molecular and therapeutic considerations [J].
Archer, DB .
EYE, 1999, 13 (4) :497-523
[7]   An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[8]   Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy [J].
Bach, LA ;
Dean, R ;
Youssef, S ;
Cooper, ME .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (03) :347-354
[9]   The Heart Outcomes Protection Evaluation (HOPE) study: relevance to ophthalmological practice? [J].
Barnett, AH .
EYE, 2000, 14 (1) :1-2
[10]  
BAUDOIN C, 1989, DIABETES, V38, P491